title: The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones.
abstract: Sex hormone-binding globulins (SHBG) is a plasma glycoprotein that binds certain steroids. It, in turn, binds to a specific receptor on cell membranes. This work was undertaken to investigate the role of steroids in the interaction of SHBG with its receptor. Because the probe for the interaction of SHBG with its receptor is 125I-SHBG, we first showed that 125I-SHBG binds [3H]dihydrotestosterone (DHT) at 4 degrees C and 37 degrees C with KD values similar to those published previously for pure radioinert SHBG. 125I-SHBG could be prevented from binding to its receptor by a variety of steroids whose relative inhibitory activity (dihydrotestosterone much greater than 2-methoxyestradiol greater than testosterone greater than estradiol much greater than methyltrienolone greater than cortisol) was almost identical to their relative ability to bind to SHBG. Because significant binding of [3H]DHT to the SHBG receptor could not be demonstrated, steroid inhibition of SHBG binding must be noncompetitive. If steroids bound to SHBG prevent binding to the SHBG receptor, then liganded SHBG should have a higher apparent KD for its receptor than unliganded SHBG. This is the case. The KD was 0.86 +/- 0.25 nM for the high affinity receptor site using liganded SHBG and 0.19 +/- 0.024 nM for unliganded SHBG. Thus, only liganded SHBG assumes a conformation that prohibits interaction with the SHBG receptor. However, when unliganded SHBG was prebound to its receptor, it retained its ability to bind [3H] DHT. The model that emerges from these observations is as follows. Unliganded SHBG can bind either steroids or receptor in a reversible reaction; SHBG bound to a steroid cannot bind to the receptor, but unliganded SHBG that first binds to the receptor can subsequently bind steroids.
authors.affiliation: Department of Medicine, St. Luke's/Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York, New York 10019.
authors.forename: D J
authors.initials: DJ
authors.lastname: Hryb
authors.forename: M S
authors.initials: MS
authors.lastname: Khan
authors.forename: N A
authors.initials: NA
authors.lastname: Romas
authors.forename: W
authors.initials: W
authors.lastname: Rosner
mesh_terms: D001665:Binding Sites; D001667:Binding, Competitive; D002462:Cell Membrane / Q000378:metabolism; D002846:Chromatography, Affinity; D013196:Dihydrotestosterone / Q000378:metabolism*; D005260:Female; D006728:Hormones / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008024:Ligands; D008297:Male; D008961:Models, Structural; D011247:Pregnancy; D011467:Prostate / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D012738:Sex Hormone-Binding Globulin / Q000302:isolation & purification / Q000378:metabolism*; D013256:Steroids / Q000494:pharmacology*
chemical_list: D006728:Hormones; D008024:Ligands; D011956:Receptors, Cell Surface; D012738:Sex Hormone-Binding Globulin; D013256:Steroids; C063572:sex hormone-binding globulin receptor; D013196:Dihydrotestosterone